Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.

[1]  Z. Bhutta.  Current concepts in the diagnosis and treatment of typhoid fever , 2006, BMJ : British Medical Journal.

[2]  Nguyen Dinh Son,et al.  The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy. , 2006, The Southeast Asian journal of tropical medicine and public health.

[3]  C. Acosta,et al.  Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow-up. , 2005, Vaccine.

[4]  A. Donner,et al.  A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; Expanding the use of Vi polysaccharide vaccine in Southeast China: A cluster-randomized trial , 2005, BMC public health.

[5]  J. Crump,et al.  The global burden of typhoid fever. , 2004, Bulletin of the World Health Organization.

[6]  S. Szu,et al.  Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. , 2003, The New England journal of medicine.

[7]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[8]  K. Brown,et al.  Salmonella vaccines for use in humans: present and future perspectives. , 2002, FEMS microbiology reviews.

[9]  R. Black,et al.  Typhoid fever in Bangladesh: implications for vaccination policy. , 2001, The Pediatric infectious disease journal.

[10]  J. Shiloach,et al.  The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. , 2001, The New England journal of medicine.

[11]  S. Zhang,et al.  Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. , 2001, Bulletin of the World Health Organization.

[12]  J. Lau,et al.  Vaccines for preventing typhoid fever , 2018, The Cochrane database of systematic reviews.

[13]  M. Levine,et al.  Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. , 1999, Vaccine.

[14]  B. Singh,et al.  Typhoid fever in children aged less than 5 years , 1999, The Lancet.

[15]  M. Falagas,et al.  Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity , 1998, BMJ.

[16]  J. Shi,et al.  [Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine]. , 1997, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[17]  J. Robbins,et al.  Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. , 1996, Vaccine.

[18]  M. Bennish.  Immunization Against Salmonella typhi , 1995 .

[19]  W. Keitel,et al.  Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. , 1994, Vaccine.

[20]  M. Levine,et al.  Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children. , 1992, The Journal of infectious diseases.

[21]  S. Hoffman,et al.  Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine , 1991, The Lancet.

[22]  M. Levine,et al.  Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial , 1990, The Lancet.

[23]  M. Levine,et al.  Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. , 1990, Vaccine.

[24]  M. Levine,et al.  Typhoid vaccines come of age , 1989, The Pediatric infectious disease journal.

[25]  M. Levine,et al.  The current status of typhoid vaccine development and clinical trials with typhoid vaccines. , 1988, Southeast Asian Journal of Tropical Medicine and Public Health.

[26]  R. Schneerson,et al.  PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER , 1987, The Lancet.

[27]  R. Thapa,et al.  Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. , 1987, The New England journal of medicine.

[28]  R. Black,et al.  LARGE-SCALE FIELD TRIAL OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULE FORMULATION , 1987, The Lancet.

[29]  M. Levine,et al.  Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules. , 1983, Developments in biological standardization.

[30]  C. Serié,et al.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results. , 1982, The Journal of infectious diseases.

[31]  C. Serié,et al.  A controlled field trial of liver oral typhoid vaccine Ty21a. , 1980, Bulletin of the World Health Organization.